Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 13/20 | 0.38 |
| ▸ | BCHE | P06276 | 8/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7838268 | 0.84 | ACHE (0.39) | ACHEBCHEDRD2HTR2AHTR7 | |
| SCHEMBL7850648 | 0.84 | ACHE (0.36) | ACHEBCHEDRD2HTR2AHTR7 | |
| SCHEMBL7843672 | 0.78 | ACHE (0.41) | ACHEBCHE | |
| SCHEMBL7838356 | 0.78 | ACHE (0.38) | ACHEBCHE | |
| SCHEMBL7850298 | 0.73 | ACHE (0.54) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL7838225 | 0.73 | ACHE (0.53) | ACHEBCHE | |
| SCHEMBL7847330 | 0.72 | GPR119 (0.33) | CYP11B2GPR119 | |
| SCHEMBL7847331 | 0.72 | GPR119 (0.33) | CYP11B2GPR119 | |
| SCHEMBL9411408 | 0.65 | ACHE (0.66) | ACHEBCHE | |
| SCHEMBL9411304 | 0.65 | ACHE (0.45) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1122252-A1 | NITROGENOUS FUSED HETEROCYCLE COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND AGENTS CONTAINING THE SAME | Takeda Chemical Industries, Ltd. (JP) | 2001-08-08 | — | — | EP | disclosed |